Sign In
to Vote &
Create Storyboards.
 

Melanoma patients may benefit from new biomarker

Medical News Today - 23 Oct 2013 12:00
Researchers have discovered a biomarker that could help predict whether patients with melanoma harboring mutations in the BRAF gene are likely to respond to BRAF-targeted treatment. The discovery could help speed up treatment decisions, say the researchers. They presented their findings at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23 in Boston, MA. About 50% of melanomas have mutations in the BRAF gene, and there are two federa...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard